Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capricor Therapeutics

14.23
+1.057.97%
Post-market: 14.590.3600+2.53%19:59 EDT
Volume:2.51M
Turnover:35.06M
Market Cap:650.42M
PE:-10.02
High:14.35
Open:13.26
Low:12.80
Close:13.18
Loading ...

Capricor Therapeutics (CAPR) Receives a Buy from Oppenheimer

TIPRANKS
·
06 Jun

Capricor Therapeutics participates in a conference call with Maxim

TIPRANKS
·
27 May

Capricor Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
27 May

Roth Capital Initiates Coverage on Capricor Therapeutics With Buy Rating

MT Newswires Live
·
20 May

Capricor Therapeutics initiated with a Buy at Roth Capital

TIPRANKS
·
20 May

Capricor Therapeutics: Buy Rating Affirmed Amid Strong Financials and Promising Regulatory Progress for Deramiocel

TIPRANKS
·
15 May

Capricor Therapeutics Price Target Maintained With a $30.00/Share by Cantor Fitzgerald

Dow Jones
·
14 May

Capricor Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Capricor Therapeutics reports Q1 EPS (53c), consensus (32c)

TIPRANKS
·
14 May

Capricor Therapeutics Q1 EPS $(0.53) Misses $(0.32) Estimate

Benzinga
·
14 May

Capricor Therapeutics Reports Q1 2025 Results: Revenues Drop to $0, Net Loss Widens to $24.4 Million, EPS at $0.53

Reuters
·
14 May

BRIEF-Capricor Therapeutics Reports First Quarter 2025 Financial Results And Provides Corporate Update

Reuters
·
14 May

Capricor Therapeutics Inc: Cash Balance of Approximately $145 Mln Expected to Support Planned Operations Into 2027

THOMSON REUTERS
·
14 May

Corrected-Capricor Therapeutics Q1 Revenue USD 0 (Corrects Amount)

THOMSON REUTERS
·
14 May

Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
14 May

Capricor Therapeutics appoints Binks as Chief Medical Officer

TIPRANKS
·
13 May

Press Release: Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

Dow Jones
·
13 May

BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official

Reuters
·
07 May

U.S.-Listed Shares of CRISPR Therapeutics Fall 10.3%, Sarepta Therapeutics Fall 20.2%

THOMSON REUTERS
·
07 May

Gene Therapy Makers Fall After US FDA Names Oncologist Vinay Prasad as Top Vaccine Official

THOMSON REUTERS
·
07 May